Table 1.

Demographic characteristics related to the efficacy of MTX treatment in women with EP

Variable	Success	Failed	p value
Age	29.5 ± 5.23	29.84 ± 5.75	0.813
Weight	73.6 ± 13.49	73.5 ± 10.52	0.974
Height	157.8 ± 5.15	158.8 ± 3.47	0.244
Gravidity	3.8 ± 2.72	3.7 ± 2.11	0.734
Parity	1.9 ± 2.07	1.8 ± 1.58	0.720
Abortion	0.86 ± 1.52	0.81 ± 1.5	0.0867
β-hCG	1380.7 ± 1341.9	3199.2 ± 2445.6	<0.001
Gestational age	6.5 ± 1.02	6.6 ± 0.92	0.671
Body mass index	29.5 ± 4.77	29.1 ± 4.05	0.691
Free fluid	49(65.2)	38(88.4)	0.09
PID	3(4.6)	3(7)	0.68
Ruptured ectopic	–	2(4.7)	0.1622
PCO	14(21.2)	21(48.8)	0.003

Data are presented as mean ± SD. p value was significant at less than 0.05

PID pelvic inflammatory diseases; PCOs polycystic ovarian syndrome; β-hCG human chorionic gonadotrophin